Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Total Liabilities

Latest as of September 2025: CN¥1.62 Billion CNY ≈ $236.76 Million USD

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has total liabilities worth CN¥1.62 Billion CNY (≈ $236.76 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Guizhou Xinbang Pharmaceutical Co Ltd growing its equity to track the company's year-over-year net asset growth rate.

Guizhou Xinbang Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002390 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
SeAH Bestee KO:001430	Korea	₩1.96 Trillion
Forward Industries Inc NASDAQ:FORD	USA	$4.82 Million
Hunan Jiudian Pharmaceutical Co Ltd SHE:300705	China	CN¥1.02 Billion
CoAsia Microelectronics TWO:8096	Taiwan	NT$5.91 Billion
Shenzhen Fuanna Bedding and Furnishing Co Ltd SHE:002327	China	CN¥833.13 Million
Kvutzat Acro Ltd. TA:ACRO	Israel	ILA4.96 Billion
China Railway Signal & Communication Corporation Limited F:RS3	Germany	€65.85 Billion
Salfacorp SN:SALFACORP	Chile	CL$1.05 Trillion

Liability Composition Analysis (2006–2024)

This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002390 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guizhou Xinbang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total liabilities of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.01 Billion ≈ $293.89 Million	-4.49%
2023-12-31	CN¥2.10 Billion ≈ $307.72 Million	-22.92%
2022-12-31	CN¥2.73 Billion ≈ $399.20 Million	-2.57%
2021-12-31	CN¥2.80 Billion ≈ $409.75 Million	-37.69%
2020-12-31	CN¥4.49 Billion ≈ $657.57 Million	-16.34%
2019-12-31	CN¥5.37 Billion ≈ $785.96 Million	-5.54%
2018-12-31	CN¥5.69 Billion ≈ $832.01 Million	+9.42%
2017-12-31	CN¥5.20 Billion ≈ $760.38 Million	+20.51%
2016-12-31	CN¥4.31 Billion ≈ $630.99 Million	+12.41%
2015-12-31	CN¥3.84 Billion ≈ $561.31 Million	+38.71%
2014-12-31	CN¥2.77 Billion ≈ $404.66 Million	+513.59%
2013-12-31	CN¥450.69 Million ≈ $65.95 Million	+44.46%
2012-12-31	CN¥311.99 Million ≈ $45.65 Million	+18.17%
2011-12-31	CN¥264.02 Million ≈ $38.63 Million	+59.23%
2010-12-31	CN¥165.81 Million ≈ $24.26 Million	-23.77%
2009-12-31	CN¥217.51 Million ≈ $31.83 Million	-7.46%
2008-12-31	CN¥235.04 Million ≈ $34.39 Million	+8.32%
2007-12-31	CN¥216.99 Million ≈ $31.75 Million	-7.73%
2006-12-31	CN¥235.18 Million ≈ $34.41 Million	--

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$787.92 Million

CN¥5.38 Billion CNY

Market Cap Rank

#10088 Global

#2689 in China

Share Price

CN¥2.77

Change (1 day)

+1.09%

52-Week Range

CN¥2.60 - CN¥4.15

All Time High

CN¥14.40